For example, within the PN group, we have previously shown that the expression of the transcriptional regulator PATZ1 is able to stratify patients in two subgroups with different overall and progression-free survival, in which higher levels of PATZ1 correlate with a longer survival [28]. Here, PATZ1 is linked to poikiloderma with neutropenia.